DXS International (STU:7EE) Total Operating Expense: €3.65 Mil (TTM As of Apr. 2025)


STU:7EE DXS International PLC STU:7EE
39 GF Score
Price €0.01
GF Value €0.02
! 2 Warning Signs
View Full Analysis

What is DXS International Total Operating Expense?

DXS International STU:7EE 39 Total Operating Expense is €3.65 Mil as of Apr. 2025. GuruFocus rates STU:7EE with a GF Score™ of 39/100 and a GF Value™ of €0.02. The stock has 2 warning signs investors should review.

DXS International's Total Operating Expense for the six months ended in Apr. 2025 was €3.65 Mil. DXS International's Total Operating Expense for the trailing twelve months (TTM) ended in Apr. 2025 was €3.65 Mil.

DXS International Total Operating Expense Related Terms

DXS International Total Operating Expense Historical Data

* Premium members only.

The historical data trend for DXS International's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DXS International Total Operating Expense Chart

DXS International Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.34 3.51 3.37 3.94 3.65

DXS International Semi-Annual Data
Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 3.34 3.51 3.37 3.94 3.65
STU:7EE
39GF Score
DXS International PLC STU:7EE
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DXS International Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Total Operating Expense for the trailing twelve months (TTM) ended in Apr. 2025 was €3.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €3.65 Mil mean?
DXS International (STU:7EE) has a Total Operating Expense of €3.65 Mil as of Apr. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on DXS International and its competitors.
Is DXS International's Total Operating Expense too high?
DXS International's current Total Operating Expense is €3.65 Mil. Overall, DXS International has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does DXS International's Total Operating Expense compare to VEEV and BTSG?
DXS International's Total Operating Expense of €3.65 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on DXS International and its competitors. DXS International's current Total Operating Expense is €3.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
DXS International (STU:7EE) has a current Total Operating Expense of €3.65 Mil. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 45% below its estimated fair value. The current Total Operating Expense is €3.65 Mil. DXS International's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For DXS International (STU:7EE), the current Total Operating Expense is €3.65 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DXS International (STU:7EE) Overvalued in 2026?

Based on GuruFocus' analysis, DXS International stock appears to be undervalued. The current stock price of €0.01 is trading 45% below its estimated GF Value™ of €0.02.

Key valuation signals for STU:7EE:

  • Total Operating Expense: €3.65 Mil
  • GF Value™: €0.02 vs. price of €0.01 (45% below fair value)
  • GF Score™: 39/100 with 2 warning signs

No single metric tells the full story. See the STU:7EE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DXS International Business Description

Other Exchanges DXSP:UK
Address 119 Saint Mary’s Road, Market Harborough, London, Leicestershire, GBR, LE16 7DT
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.
39GF Score

Get the complete analysis for STU:7EE

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price
€0.02
GF Value